Basking Biosciences
Basking Biosciences
baskingbiosciences.com

Locations

Columbus, OH, USA · Durham, NC, USA · North America

industry

Biotechnology · DeepTech · Health

Size

1 - 10 employees

Stage

Series A

founded in

2019

Basking Biosciences is focused on revolutionizing acute thrombosis treatment with its first-in-class reversible RNA aptamer, BB-031, designed to target von Willebrand Factor. The company aims to provide a safer and more effective therapy for acute ischemic stroke, with ongoing Phase II clinical trials demonstrating its commitment to addressing significant unmet medical needs. Founded on two decades of research, Basking's innovative approach leverages RNA aptamer technology to improve patient outcomes in acute revascularization therapy, positioning it as a leader in the cardiovascular therapeutic space.

Something looks off?
Open jobs at Basking Biosciences
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.